Atlas FDA

ARCHITECT Anti-HCV, Alinity i Anti-HCV

FDA premarket approval P050042/S044 · decided 2020-08-28

Approval details

PMA number
P050042
Supplement
S044
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ARCHITECT Anti-HCV, Alinity i Anti-HCV
Generic name
Assay, enzyme linked immunosorbent, hepatitis c virus
Applicant
Abbott Laboratories, Inc.
Date received
2020-07-31
Decision date
2020-08-28
Days to decision
28 days
Decision code
OK30
Product code
MZO
Advisory committee
Microbiology
Expedited review
No
Location
Abbott Park, IL
Statement
Modifications to the sourcing and testing of materials used in the manufacture of an internal reference panel, which is used for quality control evaluation during in-process reagent manufacturing.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ARCHITECT IVALPROIC ACID REAGENTS AND ARCHITECT IVALPROIC ACID CALIBRATORS, MODELS 1P35, 1P35 (K090358)Abbott Laboratories, Inc.2009-08-06
CREATININE (K061193)Abbott Laboratories, Inc.2006-06-23
PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS (K051213)Abbott Laboratories, Inc.2005-05-27
FOX PLUS PTA CATHETER (K040954)Abbott Laboratories, Inc.2004-05-11
AXSYM CYCLOSPORINE (K040761)Abbott Laboratories, Inc.2004-04-30
GEMSTAR INFUSION PUMP SYSTEM, 7 THERAPY, 6 THERAPY & PAIN MANAGEMENT (K023062)Abbott Laboratories, Inc.2002-09-30